Key result
A 43-year-old male with recurrent invasive thymoma survived for 23 years following initial surgery despite developing pleural and pericardial dissemination, myasthenia gravis, pure red cell aplasia, and Good's syndrome.
Case Report (n=1)
No
This case report demonstrates a 23-year survival in a patient with recurrent invasive thymoma and multiple autoimmune complications managed with multimodal therapy.
May support aggressive multimodal therapy in select recurrent thymoma cases; leaves open validation in larger cohorts.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Takata et al. (2017) conducted a case report in Recurrent invasive thymoma (n=1). Multidisciplinary treatment was evaluated. A 43-year-old male with recurrent invasive thymoma survived for 23 years following initial surgery despite developing pleural and pericardial dissemination, myasthenia gravis, pure red cell aplasia, and Good's syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: